
Opinion|Videos|February 7, 2025
Long-Term CAR-T Management in Myeloma: Collaborative Care and Monitoring Strategies for Patients Like Robert
This video segment examines protocols for long-term monitoring of CAR-T therapy patients, differences between academic and community settings, emerging adverse events, and strategies for multidisciplinary collaboration and care coordination to ensure seamless communication and continuity of care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is your protocol for long-term monitoring of CAR-T patients?
- How does this monitoring differ between academic and community settings?
- Are there any emerging long-term adverse events we should be aware of as our experience with CAR-T therapy grows?
- How do you approach multidisciplinary collaboration in the long-term care of CAR-T patients?
- What strategies have you found effective for coordinating care between specialists, primary care physicians, and community oncologists?
- How do you ensure seamless communication and continuity of care, especially for patients like Robert who may live far from specialized centers?
Advertisement
Related to this article

Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.

In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.

In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.

Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.

Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.

At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.

At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Accelerated Approval to Dostarlimab in dMMR Rectal Cancer
2
How AI Could Ease the Cost Crisis in Cancer Care
3
Anktiva Plus BCG: 84% of Responders Cystectomy-Free at 3 Years
4
Automated Breast Ultrasound Tied to Fewer False-Positives in Dense Breasts
5

